mitoxantrone has been researched along with Chylopericardium in 4 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Excerpt | Relevance | Reference |
---|---|---|
"16 patients with cytologically verified malignant pericardial effusions (8 with bronchial carcinoma, 7 with carcinoma of the breast, 1 with adenocarcinoma of the stomach) received an intrapericardial instillation of mitoxantrone 1-3 x10-20 mg." | 7.72 | Intrapericardial instillation of mitoxantrone in palliative therapy of malignant pericardial effusion. ( Chrissafidou, A; Gremmler, B; Malek, M; Musch, E; Nitsch, J; Rieger, J, 2003) |
"Between 1992-97, 5 patients (breast cancer-4 pts, ovarian cancer-1 pt) were admitted to the University Hospital of Tromsø due to a life-threatening MPE." | 6.69 | Mitoxantrone in malignant pericardial effusion. ( Aasebø, U; Himmelmann, A; Lunde, P; Norum, J, 1998) |
"Mitoxantrone could cause an intrapleural inflammatory reaction." | 5.29 | [Therapy of pronounced pleural and pericardial effusion in metastatic breast cancer with local mitoxantrone and radiation therapy. Presentation of the intrapleural cytologic findings during this therapy]. ( Blohmer, JU; Kohls, A; Lau, HU, 1993) |
" The pericardial effusion recurred and was then successfully treated with intrapericardial mitoxantrone." | 3.74 | Malignant pericardial effusion secondary to ovarian adenocarcinoma: a case report. ( Brown, JV; Epstein, HD; Goldstein, BH; Micha, JP; Rettenmaier, MA; Zusman, D, 2007) |
"16 patients with cytologically verified malignant pericardial effusions (8 with bronchial carcinoma, 7 with carcinoma of the breast, 1 with adenocarcinoma of the stomach) received an intrapericardial instillation of mitoxantrone 1-3 x10-20 mg." | 3.72 | Intrapericardial instillation of mitoxantrone in palliative therapy of malignant pericardial effusion. ( Chrissafidou, A; Gremmler, B; Malek, M; Musch, E; Nitsch, J; Rieger, J, 2003) |
"Between 1992-97, 5 patients (breast cancer-4 pts, ovarian cancer-1 pt) were admitted to the University Hospital of Tromsø due to a life-threatening MPE." | 2.69 | Mitoxantrone in malignant pericardial effusion. ( Aasebø, U; Himmelmann, A; Lunde, P; Norum, J, 1998) |
"Mitoxantrone could cause an intrapleural inflammatory reaction." | 1.29 | [Therapy of pronounced pleural and pericardial effusion in metastatic breast cancer with local mitoxantrone and radiation therapy. Presentation of the intrapleural cytologic findings during this therapy]. ( Blohmer, JU; Kohls, A; Lau, HU, 1993) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Musch, E | 1 |
Gremmler, B | 1 |
Nitsch, J | 1 |
Rieger, J | 1 |
Malek, M | 1 |
Chrissafidou, A | 1 |
Micha, JP | 1 |
Goldstein, BH | 1 |
Zusman, D | 1 |
Rettenmaier, MA | 1 |
Epstein, HD | 1 |
Brown, JV | 1 |
Blohmer, JU | 1 |
Kohls, A | 1 |
Lau, HU | 1 |
Norum, J | 1 |
Lunde, P | 1 |
Aasebø, U | 1 |
Himmelmann, A | 1 |
1 trial available for mitoxantrone and Chylopericardium
Article | Year |
---|---|
Mitoxantrone in malignant pericardial effusion.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Female; Follow-Up Studies; Humans; Middle Aged | 1998 |
3 other studies available for mitoxantrone and Chylopericardium
Article | Year |
---|---|
Intrapericardial instillation of mitoxantrone in palliative therapy of malignant pericardial effusion.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Dose-Response Relationship, | 2003 |
Malignant pericardial effusion secondary to ovarian adenocarcinoma: a case report.
Topics: Adenocarcinoma; Antineoplastic Agents; Female; Heart Neoplasms; Humans; Middle Aged; Mitoxantrone; O | 2007 |
[Therapy of pronounced pleural and pericardial effusion in metastatic breast cancer with local mitoxantrone and radiation therapy. Presentation of the intrapleural cytologic findings during this therapy].
Topics: Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Combined Modality Therapy; Female; Humans | 1993 |